AllQuantitative Report
Argus•February 17, 2021
Argus•February 17, 2021ZYXI: Lowering target price to $15.00
Symbols
ZYXISector(s)
Healthcare
Rating
Premium
Current Price
$14.25
Price Target
$NaN
Earnings Estimate
Premium
Summary
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products.
Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREEActions
Download Full ReportRelated Reports
- Analyst Report: Edwards Lifesciences CorporationMar 02, 2021 •
EW
- EW: Lowering target price to $90.00Feb 24, 2021 •
EW
- EW: Rating decreased to a HOLDFeb 17, 2021 •
EW
- Market Digest: AVY, BSX, EL, EA, ETN, TT, ITW, MAN, NFG, VSH, APOFeb 10, 2021 •
TT, APO, AVY, BSX, EL, VSH, MAN, EA, ITW, ETN, NFG
- Analyst Report: Boston Scientific Corp.Feb 10, 2021 •
BSX
© 2021 Verizon Media. All rights reserved.
